Allspring Global Investments’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$779K Buy
82,507
+2,594
+3% +$24.8K ﹤0.01% 1317
2026
Q1
$730K Buy
79,913
+8,225
+11% +$69K ﹤0.01% 1271
2025
Q4
$533K Buy
71,688
+6,268
+10% +$45.1K ﹤0.01% 1355
2025
Q3
$438K Sell
65,420
-647
-1% -$4.49K ﹤0.01% 1385
2025
Q2
$437K Buy
66,067
+29,238
+79% +$207K ﹤0.01% 1385
2025
Q1
$337K Buy
36,829
+12,915
+54% +$129K ﹤0.01% 1551
2024
Q4
$251K Sell
23,914
-46
-0.2% -$544 ﹤0.01% 1629
2024
Q3
$286K Buy
+23,960
New +$207K ﹤0.01% 1610
2023
Q2
– Sell
-10,730
Closed -$11.5K – 2712
2023
Q1
$11.5K Buy
10,730
+9,737
+981% +$18.6K ﹤0.01% 2580
2022
Q4
$2.59K Sell
993
-94,177
-99% -$411K ﹤0.01% 2838
2022
Q3
$666K Buy
95,170
+6,651
+8% +$52.1K ﹤0.01% 1524
2022
Q2
$603K Sell
88,519
-13,606
-13% -$139K ﹤0.01% 1540
2022
Q1
$1.44M Buy
102,125
+21,363
+26% +$286K ﹤0.01% 1679
2021
Q4
$1.17M Buy
+80,762
New +$1.15M ﹤0.01% 1842

Other funds holding BVS

Allspring Global Investments's BVS Position: Q2 2026 in Review

Allspring Global Investments increased its Bioventus (BVS) stake by 3.2% in Q2 2026, buying an estimated $24.8K and bringing the position to 82,507 shares worth $779K. The position accounts for ﹤0.01% of the portfolio, ranked #1317.

Allspring Global Investments first reported a position in BVS in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.44M in Q1 2022. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Allspring Global Investments held 82,507 shares of Bioventus worth $779K as of Q2 2026.
  • Allspring Global Investments bought 2,594 Bioventus shares in Q2 2026, an estimated $24.8K.
  • Bioventus made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1317 holding.
  • Allspring Global Investments first reported a position in Bioventus in Q4 2021 and has held it in 14 quarters since.
  • Allspring Global Investments's Bioventus position peaked at $1.44M in Q1 2022.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.